Search | TVST | ARVO Journals

Showing 1 – 20 of 22

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Autoinflammation and Autoimmunity in the Aqueous Humor of Glaucoma Patients

Eitan Katz; Yang Yang; Christian Kim; Bayasgalan Surenkhuu; Azza Dammak; Vidhya R Rao; Christine Mun; Anubhav Pradeep; Ahmad A Aref; Pooja Bhat; Jose de la Cruz; Simon Kaja; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):575.

ARVO Annual Meeting Abstract June 2023

HLA DRB1 Tissue Typing Shows Antigen HLA DRB1*04 as a Possible Predictor of Dry Eye Disease (DED)

Priyanka Dondeti; Bayasgalan Surenkhuu; Alexandria Bernal; Tanya Sheth; Christian Kim; Jessica Mun; Diana Hernandez Castro; Annette Garcia; Anubhav Pradeep; Gvozdjan Kristina; Sujata Gaitonde; Christine Mun; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3981.

ARVO Annual Meeting Abstract June 2023

Corneal Epithelial Thickness in Dry Eye Disease (DED) Patients: Association with Autoimmunity

Alexandria Bernal; Yang Yang; Bayasgalan Surenkhuu; Jessica Mun; Annette Garcia; Diana Hernandez Castro; Anubhav Pradeep; Tanya Sheth; Christian Kim; Ping-Shou Zhong; Christine Mun; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3977.

ARVO Annual Meeting Abstract June 2022

In Vivo Confocal Microscopy Reveals Cellular and Structural Abnormalities in Patients with Definite Ocular Graft-vs-Host Disease (oGVHD)

Tanya Sheth; Bayasgalan Surenkhuu; Jessie Mun; Annette Garcia; Diana Hernandez-Castro; Anubhav Pradeep; Christine Mun; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1533 – A0258.

ARVO Annual Meeting Abstract June 2021

Combinatorial Therapy with Immunosuppressive, Immunomodulatory and Tear Substitute Eyedrops (‘Triple Play’) in Recalcitrant Immunological Ocular Surface Diseases

Sarah Sunshine; Eitan Katz; Christine Mun; Jessica Mun; Caitlin Berek; Anubhav Pradeep; Bayasgalan Surenkhuu; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1306.

ARVO Annual Meeting Abstract June 2021

Recombinant Deoxyribonuclease I (DNase) Eye Drops for Ocular Graft vs Hosts Disease (oGVHD): Results of a Randomized Clinical Trial

Bayasgalan Surenkhuu; Christine Mun; Nour Atassi; Nikhil Dhall; Jessica Mun; Caitlin Berek; Christian Kim; Monazzah Akbar Sarwar; Anubhav Pradeep; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1276.

ARVO Annual Meeting Abstract June 2021

Ocular Graft vs Hosts Disease (oGVHD) After Allogenic Hematopoietic Stem Cell Transplant (allo-HSCT): A 2 Year Longitudinal, Observational Study

Nour Atassi; Bayasgalan Surenkhuu; Jessica Mun; Caitlin Berek; Anna Ahn; Nikhil Dhall; Christian Kim; Sarah Abdul-Hadi; Anubhav Pradeep; Christine Mun; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1244.

ARVO Annual Meeting Abstract July 2019

Sub-Anticoagulant Dose Heparin Dismantles Neutrophil Extracellular Traps (NETs): Therapeutic Implementations for Dry Eye Disease (DED)

Jieun Kwon; SEUNGWON AN; Illangovan Raju; Bayasgalan Surenkhuu; Anubhav Pradeep; Christine Mun; Nour Atassi; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):309.

ARVO Annual Meeting Abstract July 2019

Anti-Citrullinated Protein Antibodies (ACPA) are Present in Tear Fluid of Dry Eye Disease (DED) Patients: Diagnostic and Therapeutic Implications

Sandeep Jain; SEUNGWON AN; Jieun Kwon; Bayasgalan Surenkhuu; Illangovan Raju; Nour Atassi; Anubhav Pradeep; Christine Mun

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6786.

ARVO Annual Meeting Abstract July 2019

Recombinant Deoxyribonuclease (DNase) Eye Drops Use in Patients with Dry Eye Disease: Results of a Randomized Clinical Trial

Christine Mun; Sapna Tibrewal; Anna Ahn; Azucena Lopez; Nour Atassi; Bayasgalan Surenkhuu; Morgan Buwick; Hirali Shah; Shivali Shukla; Jessica Mun; Anubhav Pradeep; Illangovan Raju; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6759.

ARVO Annual Meeting Abstract July 2019

LIGHT Protein is a Potential Biomarker for Ocular Graft-VS-Host Disease (oGVHD)

Bayasgalan Surenkhuu; Illangovan Raju; SEUNGWON AN; Jieun Kwon; Anubhav Pradeep; Nour Atassi; Christine Mun; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6764.

Clinical Trials May 2019

A Phase I/II Placebo-Controlled Randomized Pilot Clinical Trial of Recombinant Deoxyribonuclease (DNase) Eye Drops Use in Patients With Dry Eye Disease

PDF

Christine Mun; Shilpa Gulati; Sapna Tibrewal; Yi-Fan Chen; Seungwon An; Bayasgalan Surenkhuu; Ilangovan Raju; Morgan Buwick; Anna Ahn; Ji-Eun Kwon; Nour Atassi; Anubhav Pradeep; Damiano Rondelli; Sandeep Jain
TAGS: deoxyribonucleases, dry eye syndromes, eyedrops, placebos, deoxyribonuclease i
Trans. Vis. Sci. Tech.. 2019; 8(3):10. https://doi.org/10.1167/tvst.8.3.10

ARVO Annual Meeting Abstract July 2018

Oncostatin M (OSM) Contributes to Corneal Epitheliopathy in Tear Deficient Dry Eye Disease due to Chronic ocular Graft-Vs-Host Disease (oGVHD)

Christine Mun; SEUNGWON AN; ILANGOVAN RAJU; Bayasgalan Surenkhuu; Satyabrata Sinha; Pei-Yu Wu; Anubhav Pradeep; Anna Ahn; Jieun Kwon; Azucena Lopez; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3292.

ARVO Annual Meeting Abstract July 2018

Sub-Anticoagulant Dose Heparin is a Potential Therapy for Tear Deficient Dry Eye Disease in patients with ocular Graft-Vs-Host Disease (oGVHD).

SEUNGWON AN; ILANGOVAN RAJU; Bayasgalan Surenkhuu; Satyabrata Sinha; Pei-Yu Wu; Anna Ahn; Anubhav Pradeep; Jieun Kwon; Azucena Lopez; Christine Mun; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3293.

ARVO Annual Meeting Abstract June 2017

Tear fluid neutrophils and NETs: Implications in the pathogenesis of ocular graft vs host disease

ILANGOVAN RAJU; SEUNGWON AN; Disha Varma; Anubhav Pradeep; Bayasgalan Surenkhuu; Azucena Lopez; Anisha D'costa; Christine Mun; Anna Ahn; Satyabrata Sinha; Shilpa Gulati; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3934.

ARVO Annual Meeting Abstract June 2017

A Sema7a derived RTS-disintegrin peptide binds to integrin alpha1beta1 and promotes migration of myeloid-derived suppressor cells (MDSCs)

Pei-Yu Wu; SEUNGWON AN; Hyun Lee; Disha Varma; Eunjae Kim; Zhiqiang Liu; Joy Sarkar; Anubhav Pradeep; Anna Ahn; Christine Mun; Azucena Lopez; ILANGOVAN RAJU; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):152.

ARVO Annual Meeting Abstract June 2017

Semaphorin 7a is differentially expressed in myeloid-derived suppressor cells (MDSCs) under naïve and inflammatory conditions.

SEUNGWON AN; Eunjae Kim; Disha Varma; ILANGOVAN RAJU; Anubhav Pradeep; Christine Mun; Anna Ahn; Azucena Lopez; Zhiqiang Liu; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):153.

ARVO Annual Meeting Abstract June 2017

Neutrophil Extracellular Traps (NETs) delay Epithelial Wound Healing in-vitro: Implications in chronic Ocular GVHD

Satyabrata Sinha; ILANGOVAN RAJU; SEUNGWON AN; Anubhav Pradeep; Bayasgalan Surenkhuu; Anisha D’costa; Pei-Yu Wu; Shilpa Gulati; Azucena Lopez; Christine Mun; Anna Ahn; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):160.

ARVO Annual Meeting Abstract September 2016

Sema7a peptide that spans RTS disintegrin motif binds alpha1beta1 integrin and affects neuronal adherence.

Disha Varma; Eunjae Kim; Ilangovan Raju; Zhiqiang Liu; Anubhav Pradeep; Christine Mun; Joy Sarkar; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4915.

ARVO Annual Meeting Abstract September 2016

Semaphorin 7a is differentially expressed in myeloid-derived suppressor cells (MDSCs) in naïve and inflammatory conditions.

Eunjae Kim; Disha Varma; llangovan Raju; Zhiqiang Liu; Anubhav Pradeep; Christine Mun; Joy Sarkar; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4919.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Autoinflammation and Autoimmunity in the Aqueous Humor of Glaucoma Patients

HLA DRB1 Tissue Typing Shows Antigen HLA DRB1*04 as a Possible Predictor of Dry Eye Disease (DED)

Corneal Epithelial Thickness in Dry Eye Disease (DED) Patients: Association with Autoimmunity

In Vivo Confocal Microscopy Reveals Cellular and Structural Abnormalities in Patients with Definite Ocular Graft-vs-Host Disease (oGVHD)

Combinatorial Therapy with Immunosuppressive, Immunomodulatory and Tear Substitute Eyedrops (‘Triple Play’) in Recalcitrant Immunological Ocular Surface Diseases

Recombinant Deoxyribonuclease I (DNase) Eye Drops for Ocular Graft vs Hosts Disease (oGVHD): Results of a Randomized Clinical Trial

Ocular Graft vs Hosts Disease (oGVHD) After Allogenic Hematopoietic Stem Cell Transplant (allo-HSCT): A 2 Year Longitudinal, Observational Study

Sub-Anticoagulant Dose Heparin Dismantles Neutrophil Extracellular Traps (NETs): Therapeutic Implementations for Dry Eye Disease (DED)

Anti-Citrullinated Protein Antibodies (ACPA) are Present in Tear Fluid of Dry Eye Disease (DED) Patients: Diagnostic and Therapeutic Implications

Recombinant Deoxyribonuclease (DNase) Eye Drops Use in Patients with Dry Eye Disease: Results of a Randomized Clinical Trial

LIGHT Protein is a Potential Biomarker for Ocular Graft-VS-Host Disease (oGVHD)

A Phase I/II Placebo-Controlled Randomized Pilot Clinical Trial of Recombinant Deoxyribonuclease (DNase) Eye Drops Use in Patients With Dry Eye Disease

Oncostatin M (OSM) Contributes to Corneal Epitheliopathy in Tear Deficient Dry Eye Disease due to Chronic ocular Graft-Vs-Host Disease (oGVHD)

Sub-Anticoagulant Dose Heparin is a Potential Therapy for Tear Deficient Dry Eye Disease in patients with ocular Graft-Vs-Host Disease (oGVHD).

Tear fluid neutrophils and NETs: Implications in the pathogenesis of ocular graft vs host disease

A Sema7a derived RTS-disintegrin peptide binds to integrin alpha1beta1 and promotes migration of myeloid-derived suppressor cells (MDSCs)

Semaphorin 7a is differentially expressed in myeloid-derived suppressor cells (MDSCs) under naïve and inflammatory conditions.

Neutrophil Extracellular Traps (NETs) delay Epithelial Wound Healing in-vitro: Implications in chronic Ocular GVHD

Sema7a peptide that spans RTS disintegrin motif binds alpha1beta1 integrin and affects neuronal adherence.

Semaphorin 7a is differentially expressed in myeloid-derived suppressor cells (MDSCs) in naïve and inflammatory conditions.

To View More...

You must be signed into an individual account to use this feature.